Clinical pharmacology of polyestradiol phosphate
@article{Gunnarsson1988ClinicalPO, title={Clinical pharmacology of polyestradiol phosphate}, author={P. Gunnarsson and B. Norl{\'e}n}, journal={The Prostate}, year={1988}, volume={13} }
The results of the present studies demonstrate that intramuscular injections of polyestradiol phosphate (PEP) produce not only considerably increased estrogen concentration in plasma but also maintain the same estrone/estradiol ratio as in normal men.
Topics from this paper
4 Citations
Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients
- Medicine
- The Prostate
- 1996
- 6
Steroid phosphate esters and phosphonosteroids and their biological activities
- Medicine, Biology
- Applied Microbiology and Biotechnology
- 2018
- 4
Vastly extended drug release from poly(pro-17β-estradiol) materials facilitates in vitro neurotrophism and neuroprotection
- Chemistry, Medicine
- Nature Communications
- 2019
- 5
- PDF
Differential reaction of secretory and non‐secretory proteins in hormone‐treated dunning tumor
- Biology, Medicine
- The Prostate
- 1989
- 13
References
SHOWING 1-7 OF 7 REFERENCES
Treatment of prostatic carcinoma with various types of estrogen derivatives.
- Biology, Medicine
- Vitamins and hormones
- 1975
- 62
Plasma concentrations of estradiol and testosterone in single-drug polyestradiol phosphate therapy for prostatic cancer.
- Medicine
- European urology
- 1987
- 8
Cardiovascular follow‐up of patients with prostatic cancer treated with single‐drug polyestradiol phosphate
- Medicine
- The Prostate
- 1988
- 26
Optimal testosterone concentration for the treatment of prostatic cancer.
- Medicine
- The Journal of urology
- 1985
- 34
A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy
- Medicine
- The Prostate
- 1989
- 22